SCHEMBL3137773

SCHEMBL3137773

NC(=O)c1cccnc1N1CCCCOC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 1/20 0.44
NPC1 O15118 1/20 0.44
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.42
PARP1 P09874 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
CHIA Q9BZP6 1/20 0.38
CDC7 O00311 1/20 0.38
CDK9 P50750 1/20 0.38
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL883905 0.86 KMT2A (0.58) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL28189129 0.84 KMT2A (0.60) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL353774 0.82 AURKA (0.60) KMT2AMEN1CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL21358085 0.81 AURKA (0.59) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL28275410 0.73 CHIA (0.65) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL4538970 0.73 EPHX2 (0.52) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL30945091 0.73 EPHX2 (0.52) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL30115258 0.73 KIF18A (0.52) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL22717655 0.73 KMT2A (0.59) KMT2AMEN1CYP1A2CYP2C9CYP2C19
SCHEMBL29286476 0.73 SCN10A (0.53) KMT2AMEN1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162190-A1 BIPHENYLCARBOXAMIDE DERIVATIVES AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2010-03-17 EP claimed
EP-2021328-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2009-02-11 EP claimed
WO-2008154259-A1 BIPHENYLCARBOXAMIDE DERIVATIVES AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2008-12-18 WO claimed
WO-2007131201-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2007-11-15 WO claimed
EP-2501370-A1 METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND OTHER MALIGNANCIES Novartis AG (CH) 2012-09-26 EP disclosed
EP-2464423-A1 METHODS AND COMPOSITIONS FOR TREATING LEUKEMIA Novartis AG (CH) 2012-06-20 EP disclosed
WO-2010037715-A1 SMOOTHENED ANTAGONISM FOR THE TREATMENT OF HEDGEHOG PATHWAY-RELATED DISORDERS NOVARTIS AG (CH) 2010-04-08 WO disclosed
EP-2162190-A1 BIPHENYLCARBOXAMIDE DERIVATIVES AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2010-03-17 EP disclosed
EP-2021328-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2009-02-11 EP disclosed
WO-2008154259-A1 BIPHENYLCARBOXAMIDE DERIVATIVES AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2008-12-18 WO disclosed
WO-2007131201-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2007-11-15 WO disclosed